The molecular markers showed mainly membranous and cytoplasmic immunoreactivity in pancreatic and periampullairy adenocarcinoma cells; CEA and uPAR also showed stromal immunoreactivity (Fig. 1). This evidence concerns the gene CEACAM7 and adenocarcinoma.